Camlin Fine Sciences will hold an earnings call on May 26, 2026 to discuss Q4 and FY26 audited financial results.
The call will feature Chairman & MD Ashish Dandekar, MD Nirmal Momaya, and CFO Santosh Parab.
Discussion will be based on publicly available information with no unpublished price-sensitive information shared.
This intimation is made pursuant to Regulation 30 of SEBI LODR requirements.